← FDA Drug Approvals (Drugs@FDA)

AXERT

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2001-05-07

Drug application

FDA Application #

NDA021001

Application type

New Drug Application

Brand name

AXERT

Generic name

Almotriptan Malate

Active ingredients

ALMOTRIPTAN MALATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

JANSSEN PHARMS

First approval

2001-05-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown